Concepedia

Charlotte Lemech

CL

Statistics

Publications

37

Citations

2.3K

H-Index

23

Active since

2011

Affiliations

Sarah Cannon Research Institute(Current)

University College London

Sarah Cannon

Institut Gustave Roussy

UNSW Sydney

Charlotte Lemech is an author at Sarah Cannon Research Institute specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2011–2025

37

Publications

37

Sotorasib in <i>KRAS</i> p.G12C–Mutated Advanced Pancreatic Cancer

John H. Strickler, Hironaga Satake, Thomas J. George et al. · New England Journal of Medicine · 2022 · 468 citations · Full text

, , +11

IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

Michael S. Anglesio, Joshy George, Hagen Kulbe et al. · Clinical Cancer Research · 2011 · 261 citations · Full text

, , +17

Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development

Allison Jones, Andrew E. Teschendorff, Quanxi Li et al. · PLoS Medicine · 2013 · 156 citations · Full text

, , +17

A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors

Jean‐Charles Soria, Hui Gan, Sarah P. Blagden et al. · Annals of Oncology · 2016 · 145 citations · Full text

, , +14

A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors

Joaquı́n Mateo, Gopinath Ganji, Charlotte Lemech et al. · Clinical Cancer Research · 2017 · 143 citations · Full text

, , +17

1–5 of 37